PATENT CLAIM ANALYSIS

Application Number: 15912426
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "426000"]

Abstract:
Bioactive agents are embedded in a cross-linked dextran and coated with a bioresorbable polymer. When implanted in a mammal, the coated cross-linked dextran composition produces controlled release of the embedded bioactive agent.

Claim (Index 6):
The medical implant as in  claim 1 , wherein the cross-linking hydrazide is at least one dihydrazide selected from the group consisting of succinic acid dihydrazide, glutaric acid dihydrazide, adipic acid dihydrazide, pimelic acid dihydrazide, suberic acid dihydrazide, azelaic acid dihydrazide, sebacic acid dihydrazide, undecanedioic acid dihydrazide, dodecanedioic acid dihydrazide, brassylic acid dihydrazide, tetradecanedioic acid dihydrazide, pentadecanedioic acid dihydrazide, thapsic acid dihydrazide, octadecanedioic acid dihydrazide.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.34615
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11983454', '13228267', '13867929', '14191396', '15314168']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7590102721959908
- 35 USC 102 Novelty (BERT): 0.4794567529870023
- Combined Prediction Score: 0.731054920275092
- Mean Citation Score: 189.65783
- Max Citation Score: 229.59799
- Similarity Product: 194.6923190931177

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test